Literature DB >> 12554138

Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma.

Michael S Alexander1, Melissa M Kiser, Travis Culley, John R Kern, John W Dolan, James D McChesney, Jan Zygmunt, Steve J Bannister.   

Abstract

A GLP-validated, sensitive and specific LC-MS-MS method for the quantification of paclitaxel and its 6-alpha- and 3'-p-hydroxy metabolites is presented. A 0.400 ml plasma aliquot is spiked with a (13)C(6)-labeled paclitaxel internal standard and extracted with 1 ml methyl-tert.-butyl ether. The ether is evaporated and the residue is reconstituted in 130 microl of 30% aqueous acetonitrile (ACN) containing 0.1% trifluoroacetic acid. Isocratic HPLC analysis is performed by injecting 50 microl of the reconstituted material onto a 50x2.1 mm C(18) column with an ACN-water-acetic acid (50:50:0.1) mobile phase at 200 microl/min flow. Detection is by positive ion electrospray followed by multiple reaction monitoring of the following transitions: paclitaxel (854>509 u), 6-alpha-hydroxy paclitaxel (870>525 u), 3'-p-hydroxy paclitaxel (870>509 u) and internal standard (860>509 u). Quantification is by peak area ratio against the 13C(6) internal standard. The method range is 0.117-117 nM (0.1-100 ng/ml) for paclitaxel and both metabolites using a 0.400 ml human or dog plasma sample. Analysis time per sample is less than 5 min. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554138     DOI: 10.1016/s1570-0232(02)00913-3

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometry.

Authors:  Haoying Yu; Robert M Straubinger; Jin Cao; Hao Wang; Jun Qu
Journal:  J Chromatogr A       Date:  2008-09-19       Impact factor: 4.759

2.  Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment.

Authors:  Erin R Gardner; William Dahut; William D Figg
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-28       Impact factor: 3.205

3.  Adduct formation in quantitative bioanalysis: effect of ionization conditions on paclitaxel.

Authors:  Kjell A Mortier; Guo-Fang Zhang; Carlos H van Peteghem; Willy E Lambert
Journal:  J Am Soc Mass Spectrom       Date:  2004-04       Impact factor: 3.109

4.  High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection.

Authors:  Anders Andersen; David J Warren; Paal F Brunsvig; Steinar Aamdal; Gunnar B Kristensen; Harald Olsen
Journal:  BMC Clin Pharmacol       Date:  2006-01-13

5.  Preliminary results of identification and quantification of paclitaxel and its metabolites in human meconium from newborns with gestational chemotherapeutic exposure.

Authors:  Elyce Cardonick; Robert Broadrup; Peining Xu; Mary T Doan; Helen Jiang; Nathaniel W Snyder
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

6.  A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study.

Authors:  Bianca Posocco; Mauro Buzzo; Andrea Follegot; Luciana Giodini; Roberto Sorio; Elena Marangon; Giuseppe Toffoli
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.